|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.18 HKD | +1.00% |
|
+9.02% | -25.56% |
| 06-25 | 3Sbio Inc. Declares a Final Dividend for the Year Ended 31 December 2025 | CI |
| 05-28 | Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 18.07 | 19.66 | 23.14 |
| Spread/Res. | -0.39% | -8.44% | -22.21% |
| Spread/Supp. | +11.46% | +18.19% | +14.80% |
| Support | 16.15 | 15.23 | 15.68 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 1530 Stock
- Charts 3SBio Inc.
Select your edition
All financial news and data tailored to specific country editions
